Pharmacokinetics, pharmacodynamics and tolerability of opicapone, a novel catechol-O-methyltransferase inhibitor, in healthy subjects: prediction of slow enzyme-inhibitor complex dissociation of a short-living and very long-acting inhibitor.
Clin Pharmacokinet
; 52(2): 139-51, 2013 Feb.
Article
en En
| MEDLINE
| ID: mdl-23248072
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Oxadiazoles
/
Inhibidores Enzimáticos
/
Inhibidores de Catecol O-Metiltransferasa
/
Antiparkinsonianos
Tipo de estudio:
Clinical_trials
/
Prognostic_studies
/
Risk_factors_studies
Límite:
Adolescent
/
Adult
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Clin Pharmacokinet
Año:
2013
Tipo del documento:
Article
País de afiliación:
Portugal
Pais de publicación:
Suiza